Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications

Trends in Pharmacological Sciences

Volumn 29, Issue 12, 2008, Pages 626-632

  El Khoury, Joseph ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALGRANULIN B; CD40 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; COLONY STIMULATING FACTOR 1; GREEN FLUORESCENT PROTEIN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PRESENILIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BONE MARROW TRANSPLANTATION; DEGENERATIVE DISEASE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MICROGLIA; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BONE MARROW CELLS; CHEMOKINES; MICE; MICE, TRANSGENIC; MICROGLIA; PHAGOCYTOSIS; RECEPTORS, CCR2; SIGNAL TRANSDUCTION;

EID: 56349166514     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2008.08.004     Document Type: Review

References (64)

1. Jalbert J.J., et al. Dementia of the Alzheimer type. Epidemiol. Rev. (2008). http://epirev.oxfordjournals.org 10.1093/epirev/mxn008
2. Mayeux R. Alzheimer's disease: epidemiology. Handb Clin Neurol 89 (2008) 195-205
3. Mott R.T., and Hulette C.M. Neuropathology of Alzheimer's disease. Neuroimaging Clin. N. Am. 15 (2005) 755-765
4. Gomez-Isla T., et al. Neuropathology of Alzheimer's disease. Handb Clin Neurol 89 (2008) 233-243
5. Selkoe D.J. The origins of Alzheimer disease: a is for amyloid. J. Am. Med. Assoc. 283 (2000) 1615-1617
6. Spires T.L., and Hyman B.T. Neuronal structure is altered by amyloid plaques. Rev. Neurosci. 15 (2004) 267-278
7. Maragakis N.J., and Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2 (2006) 679-689
8. Heneka M.T., and O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184 (2007) 69-91
9. McGeer P.L., et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79 (1987) 195-200
10. Perlmutter L.S., et al. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci. Lett. 119 (1990) 32-36
11. D'Andrea M.R., et al. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging 25 (2004) 675-683
12. Frautschy S.A., et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152 (1998) 307-317
13. Chen K., et al. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell. Mol. Immunol. 3 (2006) 163-169
14. El Khoury J., et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382 (1996) 716-719
15. Coraci I.S., et al. CD36, a Class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils. Am. J. Pathol. 160 (2002) 101-112
16. El Khoury J.B., et al. CD36 mediates the innate host response to β-amyloid. J. Exp. Med. 197 (2003) 1657-1666
17. Haga S., et al. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601 (1993) 88-94
18. Giulian D., et al. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16 (1996) 6021-6037
19. London J.A., et al. Neurocytopathic effects of β-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4147-4152
20. Laporte V., et al. CD40 ligation mediates plaque-associated tau phosphorylation in β-amyloid overproducing mice. Brain Res. 1231 (2008) 132-142
21. El Khoury J., et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13 (2007) 432-438
22. Simard A.R., et al. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006) 489-502
23. Shaftel S.S., et al. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J. Clin. Invest. 117 (2007) 1595-1604
24. Town T., et al. Blocking TGF-β-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14 (2008) 681-687
25. Hickman S.E., et al. Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28 (2008) 8354-8360
26. Bolmont T., et al. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 28 (2008) 4283-4292
27. Meyer-Luehmann M., et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451 (2008) 720-724
28. Heiple J.M., et al. Macrophages form circular zones of very close apposition to IgG-coated surfaces. Cell Motil. Cytoskeleton 15 (1990) 260-270
29. Ling E.A. Electron microscopic study of macrophages appearing in a stab wound of the brain of rats following intravenous injection of carbon particles. Arch. Histol. Jpn. 42 (1979) 41-50
30. Imamoto K. Origin of microglia: cell transformation from blood monocytes into macrophagic ameboid cells and microglia. Prog. Clin. Biol. Res. 59A (1981) 125-139
31. Sievers J., et al. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: morphology. Glia 12 (1994) 245-258
32. Eglitis M.A., and Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4080-4085
33. Simard A.R., and Rivest S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18 (2004) 998-1000
34. Hess D.C., et al. Hematopoietic origin of microglial and perivascular cells in brain. Exp. Neurol. 186 (2004) 134-144
35. Priller J., et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 7 (2001) 1356-1361
36. 2+ monocytes only under defined host conditions. Nat. Neurosci. 10 (2007) 1544-1553
37. Ajami B., et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10 (2007) 1538-1543
38. Davoust N., et al. From bone marrow to microglia: barriers and avenues. Trends Immunol. 29 (2008) 227-234
39. Malm T.M., et al. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol. Dis. 18 (2005) 134-142
40. Djukic M., et al. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 129 (2006) 2394-2403
41. Remington L.T., et al. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 170 (2007) 1713-1724
42. Kokovay E., and Cunningham L.A. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease. Neurobiol. Dis. 19 (2005) 471-478
43. Viola A., and Luster A.D. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 171-197
44. Zachariae C.O., et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 171 (1990) 2177-2182
45. Weber C., et al. Sequential regulation of α4β1 and α5β1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J. Cell Biol. 134 (1996) 1063-1073
46. Barlic J., and Murphy P.M. Chemokine regulation of atherosclerosis. J. Leukoc. Biol. 82 (2007) 226-236
47. Izikson L., et al. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192 (2000) 1075-1080
48. Proudfoot A.E., et al. The use of chemokine antagonists in EAE models. J. Neuroimmunol. 198 (2008) 27-30
49. Ishizuka K., et al. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin. Neurosci. 51 (1997) 135-138
50. Prat E., et al. The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with β-amyloid protein. Neurosci. Lett. 283 (2000) 177-180
51. Quinones M.P., et al. Role of astrocytes and chemokine systems in acute TNFα induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-κB and Akt. Mol. Cell. Neurosci. 37 (2008) 96-109
52. Boisvert W.A., et al. Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am. J. Pathol. 168 (2006) 1385-1395
53. Braunersreuther V., et al. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 373-379
54. Zernecke A., et al. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107 (2006) 4240-4243
55. Geissmann F., et al. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
56. Ancuta P., et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197 (2003) 1701-1707
57. Nahrendorf M., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204 (2007) 3037-3047
58. Serbina N.V., and Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7 (2006) 311-317
59. Tsou C.L., et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117 (2007) 902-909
60. Walker D.G., et al. Gene expression profiling of amyloid β peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22 (2001) 957-966
61. Xia M.Q., and Hyman B.T. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5 (1999) 32-41
62. Ransohoff R.M., et al. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int. Rev. Neurobiol. 82 (2007) 187-204
63. Cardona A.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006) 917-924
64. Lefterov I., et al. Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment. Mol. Neurodegener. 2 (2007) 20